Catalyst Pharmaceuticals Inc (CPRX) — Free Cash Flow Generation Index
Catalyst Pharmaceuticals Inc (CPRX) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $59.56 Million represents 1% of operating cash flow ($59.59 Million). Explore Catalyst Pharmaceuticals Inc (CPRX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Catalyst Pharmaceuticals Inc Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Catalyst Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see Catalyst Pharmaceuticals Inc operating cash flow efficiency.
Annual Free Cash Flow Generation for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year Free Cash Flow Generation Index for Catalyst Pharmaceuticals Inc. Check CPRX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $208.61 Million | $208.67 Million | $58.00K | ▲ +0.2% |
| 2024 | 1.00x | $239.25 Million | $239.81 Million | $556.00K | ▲ +131.6% |
| 2023 | 0.43x | $61.86 Million | $143.60 Million | $81.74 Million | ▼ -56.9% |
| 2022 | 1.00x | $116.02 Million | $116.05 Million | $29.00K | ▲ +1.7% |
| 2021 | 0.98x | $59.35 Million | $60.37 Million | $1.02 Million | ▼ -1.7% |
| 2020 | 1.00x | $45.02 Million | $45.03 Million | $11.39K | ▲ +0.0% |
| 2019 | 1.00x | $34.59 Million | $34.61 Million | $19.37K | — |